Anatra Tablet
NDC Package 83641-001-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Anatra (anas barbariae) tablets is aNATRA may be taken regularly as a preventative. This formulation utilizes a tablet delivery system. Marketed by Anatra Llc, this product is identified by NDC 83641-001.

Identification & Billing

NDC Package Code
83641-001-01
Package Description
30 TABLET in 1 BOTTLE, PLASTIC
Product Code
83641-001
11-Digit Billing Format
83641000101

Clinical Specifications

Proprietary Name
Anatra
Non-Proprietary Name
Anas Barbariae
Substance Name
Cairina Moschata Heart/liver Autolysate
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE 200 [hp_C]/1
Usage Information
ANATRA may be taken regularly as a preventative. Adults and children 2 years of age and older: Dissolve entire tablet in mouth every 6 hours, up to 3 times a day. Children under two years of age: Ask a Doctor.

Regulatory & Marketing

Labeler Name
Anatra Llc
Product Type
Human Otc Drug
Marketing Category
UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
Start Marketing Date
09-01-2023
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (83641-001). Click a package code to view its specific billing and regulatory data.

83641-001-02
60 TABLET in 1 BOTTLE, PLASTIC

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 83641-001-01 identifies a specific commercial package of 30 tablet in 1 bottle, plastic of Anatra, a human over the counter drug labeled by Anatra Llc. This tablet is formulated for oral use and contains cairina moschata heart/liver autolysate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Anatra Llc on September 01, 2023. The current certification is valid through December 31, 2026.

How is this Anatra Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 83641000101. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
83641-001-01
11-Digit CMS (5-4-2)
83641-0001-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.